The list below contains Medical Device’s Field Corrective Action for the month of April 2022. This list provides field corrective action reporting information to MDA by establishment in accordance to requirement stipulated in Section 41, Act 737 and Regulation 6 of Medical Device (Duties and Obligations of Establishment) Regulations 2019.

Field Corrective Action (FCA) is part of a post-marketing risk assessment measure to ensure the continued safe use of medical devices in the Malaysia market. It is a corrective or preventive action in relation to a medical device which may include –

  • The return of the medical device to the establishment;
  • Modification of the medical device;
  • Exchange of the medical device;
  • Destruction of medical device; or
  • Specific advice on the use of the medical device. 

If you have experienced any safety and performance issue with one of the medical devices listed for FCA action, please seek advice from your medical device authorised representative as soon as possible.

 

Date received

Title of FCA

Affected

Medical Device

MDA Reference Number

MDA Registration Number

Description

Local Establishment

Contact Detail

5 April 2022

 FCA Initial Report on VITEK 2 - results sent to the LIS via HL7 format for antibiotic screen tests and synergy tests do not include the user-corrected or AES-corrected interpretation.

VITEK 2

MDA/FCA/2022-P053

IVDB82052370619

IVDB10305720-46040

During internal bioMérieux testing, a VITEK® 2 software issue was identified whereby results sent to the LIS via HL7 format for antibiotic screen tests and synergy tests do not include the user-corrected or AES-corrected interpretation.

Mimi Asmida Ridhwan

Biomerieux Malaysia Sdn Bhd

6 April 2022

 FCA Initial Report on XEVO - the final sample of a batch may have tests not displayed when viewed within the NeoLynx or IonLynx processing browser and in reports generated from the browser.

Xevo TQ

Xevo TQD

Xevo TQ‐S

MDA/FCA/2022-P054

IVD81401752618A

IVDA3194720‐48164

After investigation a vulnerability has been found within the NeoLynx or IonLynx processing browser, where the final sample of a batch may have tests not displayed when viewed within the NeoLynx or IonLynx processing browser and in reports generated from the browser.

Yu Seen Ng

Emergo Malaysia Sdn. Bhd.

7 April 2022

 FCA Initial Report on Vivo 45 , Vivo 45 LS, NIPPY 4, 4+ ventilators - exceptional condition where a forced shutdown of one of the processors in the ventilator could cause the ventilator to stop treatment without alarming.

Vivo 45, Vivo 45LS, Nippy 4, Nippy 4+

MDA/FCA/2022-P055

GC69517810218 GC3362520-49980

During an internal bench test of this processor monitoring function, Breas has discovered an exceptional condition where a forced shutdown of one of the processors in the ventilator could cause the ventilator to stop treatment without alarming. The test was performed as a challenge test using a special, internal version of the ventilator firmware, which contains code that is not present in any released version of the firmware.

Amaliena

Somnotec (M) Sdn. Bhd.

14 April 2022

 Initial Report of FA1236  Cobalt_Crome Diagnostic Reset due to Stuck TelB

CareLink SmartSync Device Manager

Crome MRI SureScan

Crome HF MRI SureScan

Cobalt MRI SureScan

Cobalt HF MRI SureScan

MDA/FCA/2022-P056

GD6436621-54363, GD6958021-54359, GD6507621-54621, GD6989721-54361, GC2276920-44558

Some Cobalt and Crome devices may encounter a persistent “session-active” flag following the use of inductive telemetry. The persistent session-active flag is the result of a telemetry connection error that can occur when intermittent or disrupted signals manifest while communicating with the device at the end of the telemetry session. Inductive telemetry with a Cobalt/Crome device typically occurs during device interrogation with a CareLink Express™ Mobile reader head.

Wong Wai Yi

Medtronic Malaysia Sdn Bhd

Office +603-78838000|

wong.waiyi@medtronic.com

14 April 2022

 FCA Initial Report of AXIOM Sensis XP, Sensis and Sensis Lite - Software crash during split screen, Software crash due to system internal timeout and Missing regular reboot of the system may result in frozen vital signs

Sensis / Sensis Lite

MDA/FCA/2022-P057

GC58192270417

Issue 1 - Software crash during split screen: This software crash might prevent the operator from continuing a study, which may result in a delay in the examination.

Issue 2 - Software crash due to system internal timeout: This can prevent the operator from starting or continuing a study and may result in a delay in starting or continuing the examination.

Issue 3 – Missing regular reboot of the system may result in frozen vital signs: This may lead to incorrect or insufficient basis for diagnostic or therapeutic decisions.

Nur Ayuni

QUALITY TECHNOLOGY EXECUTIVE

SIEMENS HEALTHCARE SDN BHD

15 April 2022

 FCA Initial Report on Atellica IM1300 & 1600 Analyzers - Atellica IM T3 Assay may produce inconsistent results for Atellica IM T3 Assay (Triiodothyronine) reagent kit

Atellica IM Total Triiodothyronine (T3) 600T

Atellica IM Total Triiodothyronine (T3) 120T

MDA/FCA/2022-P058

IVDB66176172318

Siemens Healthcare Diagnostics Inc. has confirmed that Atellica IM analyzers listed in Table 1

may produce inconsistent results for Atellica IM T3 Assay (Triiodothyronine) reagent kit lots ending in numbers below 244 after scanning the Master Curve (MC) Card for reagent lots ending in 244 or above

ZOE CHOW NGAH CHIANN

ASSISTANT MANAGER - QUALITY

SIEMENS HEALTHCARE SDN BHD

18 April 2022

FSCA Initial Report on KARL STORZ Flexible Endoscopes - the required efficacy level of disinfection using CIDEX OPA without any additional process step was not achieved.

KARL STORZ Flexible Endoscopes

MDA/FCA/2022-P059

 

Supplemental validation testing of the efficacy of the manual high-level disinfection process using CIDEX OPA as a single step was performed. Testing showed that the required efficacy level of disinfection using CIDEX OPA without any additional process step was not achieved.

Sarah Woon

Operations Manager

UMMI Surgical Sdn Bhd

18 April 2022

 FCA Initial Report on ORTHO VISION Analyser - Potential for Mis-Association of Test Results with Improper Usage of Assign to Position Feature

ORTHO VISION® Analyzer (BioVue)

ORTHO VISION® Max Analyzer (BioVue)

MDA/FCA/2022-P060

IVDD33166265118

Ortho Clinical Diagnostics received complaints in which customers obtained unexpected results on their ORTHO VISION analyser.

Siti Noor Liyana Abd Gani

Regulatory Affairs Quality Assurance

DiagnostiCARE Sdn Bhd

20 April 2022

Initial FCA Report on RANDOX CALIBRATOR CKMB - realigned of CK-MB Calibrator CK2393

RANDOX CALIBRATOR CKMB

MDA/FCA/2022-P061

IVDC2813712916

Randox have realigned CK-MB Calibrator CK2393, lot number 4410CK.

Mark Ong,

Biorex Mannheim Malaysia Sdn Bhd

22 April 2022

 FCA Initial Report on Heartware Ventricular Assist System (HVAD) - to provide information on upcoming updates to the Instruction for Use (IFU), Emergency Responder Guide (ERG), and Patient Manual (PM) for the HeartWare™ Ventricular Assist Device (HVAD™) system.

Heartware Ventricular Assist System (HVAD)

MDA/FCA/2022-P062

GD74345985518

Medtronic is writing to provide information on upcoming updates to the Instruction for Use (IFU), Emergency Responder Guide (ERG), and Patient Manual (PM) for the HeartWare™ Ventricular Assist Device (HVAD™) system.

Wong Wai Yi

Medtronic Malaysia Sdn Bhd

22 April 2022

 FCA Initial Report on PHADIA 200 - An issue in the Phadia 200 software can cause the pipette to be placed too high above the dilution plate.

Phadia 200

MDA/FCA/2022-P063

IVDA1670544317

An issue in the Phadia 200 software can cause the pipette to be placed too high above the dilution plate

Ng Boon Thiam

Biomarketing Services (M) Sdn Bhd

22 April 2022

 FCA Initial Report of Arrow Kits and Sets with Introducer Needles - Introducer needle hub in some Arrow kits crack under stress during the catheterization procedure.

Arrow Kits

MDA/FCA/2022-P064

 

Teleflex has received complaints reporting that the introducer needle hub in some Arrow® kits crack under stress during the catheterization procedure.

Chuah Siew See

Teleflex Medical Sdn Bhd

26 April 2022

 FCA Initial Report on CARESCAPE R860 Ventilators - the alarm for Back up batteries in CARESCAPE R860 Ventilators manufactured on or after April 1, 2019 that alerts the u 4455 065ser on battery run time remaining could potentially be inaccurate.

Datex-Ohmeda CARESCAPE R860 ventilator

MDA/FCA/2022-P065

GC97483321017

Back up batteries in CARESCAPE R860 Ventilators manufactured on or after April 1, 2019 and GE Healthcare recommended replacement back up batteries distributed on or after April 1, 2019 for CARESCAPE R860, Engström Carestation and Engström PRO can fail earlier than their estimated life. For these batteries, the alarm that alerts the user on battery run time remaining could potentially be inaccurate.

Benedict Lee

Regulatory leader

GE Healthcare Sdn Bhd

27 April 2022

 FCA Initial Report on the on-off suction unit Flow-c anesthesia systems in Maquet 4456 066Flow-I Anesthesia Systems

Flow-C and Flow-E (Maquet Flow-I Anesthesia System

MDA/FCA/2022-P066

GC25644700318

It has come to our attention that the suction unit on/off knob material on the Getinge Flow-c and Getinge Flow-e anesthesia systems have a tendency to crack

Syahirah Fatini

Regulatory Executive

IDS Medical Systems (M) Sdn Bhd

27 April 2022

 Field Safety Corrective Action (MY-FSN-CPS-2020-001 version 9) related to Elecsys CA 19-9: non reproducible elevated results with certain reagent lots on cobas e 801.

Elecsys CA 19-9

MDA/FCA/2022-P067

IVDC53289203518

As described in the former versions of MY-FSN-CPS-2020-001, Elecsys CA 19-9 lots 416245, 464449, 483123 (all three expired), 504743 and 568976 on cobas e 801 showed in internal investigations and/or customer complaints an increased rate of non-reproducible elevated results.

Tiffany Soon

Regulatory Affairs Senior Executive

Roche Diagnostics (M) Sdn. Bhd.

27 April 2022

 Initial Report on Heartware Ventricular Assist System (HVAD) - wear marks, which indicate the impellers were rotating non-concentrically and contacting the center posts of the pumps.

Heartware Ventricular Assist System (HVAD)

MDA/FCA/2022-P068

GD74345985518

Medtronic is informing all HVAD customers about a new investigation into a possible performance issue. Medtronic has received 3 confirmed complaints of patients that presented with suspicion of a pump thrombosis; however, upon inspection of the 3 returned pumps a device malfunction was identified.

Wong Wai Yi

Associate Regulatory Affairs Specialist

Medtronic Malaysia Sdn Bhd

27 April 2022

Initial Report on Somatom Force - sporadic interference signals may occur due to an error within the patient table position encoder during patient table position.

Somatom Force

MDA/FCA/2022-P069

GC89196147817

During the transmission of the patient table position information, sporadic interference signals may occur due to an error within the patient table position encoder

NUR AYUNI BINTI ABAS

QUALITY TECHNOLOGY EXECUTIVE

SIEMENS HEALTHCARE SDN BHD

28 April 2022

 FCA Initial Report on  falsely elevated results when using the Alinity m HBV Assay

Alinity m HBV

MDA/FCA/2022-P070

IVDC9888620-39112

Abbott has received reports of falsely elevated results when using the Alinity m HBV AMP Kit. Data analysis has determined that carryover from a well containing high titer HBV to a neighboring well is a potential contributing factor

Leon Teo

RAQA Manager

Abbott Laboratories (M) Sdn Bhd

27 April 2022

 Voluntary field correction notification for the CORTRAK* 2 Enteral Access System (EAS) due to reports of 60 injuries and 23 patient deaths related to misplacement of nasogastric feeding tubes while using the CORTRAK* 2 Enteral Access System

CORTRAK*2 Enteral Access System

MDA/FCA/2022-P077

GA4825520-47748

Avanos Medical, Inc. is conducting a voluntary field correction for the CORTRAK* 2 Enteral Access System (EAS) due to reports of 60 injuries and 23 patient deaths related to misplacement of nasogastric feeding tubes while using the CORTRAK* 2 Enteral Access System, since 2015.

Nur Dalila Umar

Quality & Regulatory Executive

Global Healthcare Logistics (M) Sdn Bhd